← back to search

Richard J. Knight

Barwon Health · GB
Area of research
Transplantation · Surgery
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, Organ Transplantation Techniques and Outcomes, Organ Donation and Transplantation, and Transplantation: Methods and Outcomes.
h-index
36
citations
4,213
works
189
NIH funding
primary concept
Medicine
email

Recent publications

Carbon Emissions From Different Dialysis Modalities: A Life Cycle Assessment
American Journal of Kidney Diseases 2025cited by 15position: middledoi
The Carbon Footprint of Peritoneal Dialysis in Australia
Journal of the American Society of Nephrology 2024cited by 40position: middledoi
Updating the Data: The Resource Consumption of Modern-Day Hemodialysis Systems
Kidney International Reports 2024cited by 26position: middledoi
The Impact of Kidney/Pancreas Transplantation on Peripheral Arterial Disease.
2024cited by 1position: contributordoi
Deceased donor vein extension grafts for right living donor kidney transplantation.
2023cited by 1position: contributordoi
Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
The Lancet Infectious Diseases 2022cited by 78position: middledoi
mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients
American Journal of Transplantation 2022cited by 21position: middledoi
mTOR inhibitors, mycophenolates, and other immunosuppression regimens on antibody response to SARS-CoV-2 mRNA vaccines in solid organ transplant recipients.
2022cited by 20position: contributordoi
Early humoral immune response to two doses of severe acute respiratory syndrome coronavirus 2 vaccine in a diverse group of solid organ transplant candidates and recipients.
2022cited by 10position: contributordoi
Assessment of infectious complications in elderly kidney transplant recipients receiving induction with anti-thymocyte globulin vs basiliximab.
2020cited by 19position: contributordoi
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function
Transplantation Proceedings 2019cited by 38position: middledoi
Ciprofloxacin for BK viremia prophylaxis in kidney transplant recipients: Results of a prospective, double-blind, randomized, placebo-controlled trial.
2019cited by 13position: contributordoi
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice
Transplantation Proceedings 2018cited by 21position: middledoi
Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial
American Journal of Kidney Diseases 2015cited by 99position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 5 papers (2019–2024)A. Osama Gaber · Methodist Hospital5 papers (2019–2024)Duc T. Nguyen · Baylor College of Medicine4 papers (2019–2024) · 4 papers (2019–2024) · 4 papers (2019–2024) · 4 papers (2019–2024)Edward A. Graviss · Houston Methodist4 papers (2019–2024)Katherine A. Barraclough · University of Queensland3 papers (2024–2025) · 3 papers (2024–2025)Linda W. Moore · Cornell University3 papers (2019–2022)Scott McAlister · Melbourne Health3 papers (2024–2025)Forbes McGain · Star Technology and Research (United States)2 papers (2024–2025)Stephen P. McDonald · Sheffield Hallam University2 papers (2024–2025) · 2 papers (2018–2019) · 2 papers (2018–2019)Samantha A. Kuten · Methodist Hospital2 papers (2019–2020) · 2 papers (2022–2024) · 2 papers (2018–2019)Daniel G. Maluf · University of Virginia2 papers (2018–2019)R. Mark Ghobrial · Houston Methodist2 papers (2022–2022)